Showing 2 results for Mashayekhi
Khoshdel Rad N, Mashayekhi F, Mirzajani E,
Volume 6, Issue 1 (spring-summer[PERSIAN] 2012)
Abstract
Abstract Background and objectives: C-Met is a proto-oncogene that encodes a protein known as hepatocyte growth factor receptor (HGFR). The HGF receptor possesses tyrosine -kinase activity and it is essential for embryonic development, wound healing and cancer. Many proteins are proteolytically released from the surface by a process known as ectodomain shedding. Shedding occurs under normal physiologic conditions and can be increased in certain pathologies. C-Met can be seen among many receptors for which ectodomain shedding has been shown. The aim of this study was to determine the concentration of soluble c-Met in the cerebrospinal fluid (CSF) and serum samples of patients with viral and bacterial meningitis. Material and Methods: in this study, 75 CSF and serum samples of patients with bacterial meningitis, 71 with viral meningitis and 82 normal controls were investigated. The soluble c-Met concentration was determined by enzyme linked immunosorbent assay (ELISA). Result: the amount of soluble c-met in CSF of patients with bacterial meningitis ( 83.91±5.50), viral meningitis ( 80.41±4.71) and control group ( 22.66±3.39) are compared with that in serum of patients with bacterial meningitis ( 561.58±25.87), viral meningitis ( 550.50 ±34.34) and control group ( 256.25±18.55). There is significant increase in the CSF and serum’s soluble c-Met expression in the patients with meningitis, in comparison with control group. Conclusion: The data presented here indicate that soluble c-Met is a constant component of human serum and CSF, but it can not be used for differentiating bacterial meningitis from viral meningitis. Key words: Soluble c-Met, concentration, cerebrospinal fluid, serum, meningitis
F Mashayekhi, F Rajaei,
Volume 6, Issue 2 (Autumn- Winter [PERSIAN] 2012)
Abstract
Abstract
Background and objectives: Meningitis is one of the most common infectious of the central nervous system (CNS), defined as an inflammation of the meninges. LIF is a potent pro-inflammatory factor. Cerebrospinal fluid (CSF) contains the growth factors and cytokines whose concentrations have been changed in most neurological diseases. The aim of this study was to determine the LIF concentration of serum and CSF in the children with bacterial meningitis.
Material and Methods: In this study, the total protein concentration (TPC) and LIF in the serum and CSF of normal subjects and children with bacterial meningitis were measured by enzyme linked immunosorbent assay (ELISA).
Results: the Values of serum TPC for children with meningitis (74.17±7.73 g/L) and controls (73.50±7.28 g/L) are not different significantly (P=0.7), and the TPC in the CSF of children suffering from meningitis and controls are 35±0.03 and 0.34±0.05 g/L, respectively (P=0.65). The concentration of serum LIF for children with meningitis( 253±19.14 ng/ml) is higher than that of controls (49.75±8.97 ng/ml), and also the concentration of LIF in the CSF of the children with meningitis (116.25±8.60 ng/ml ) is significantly higher than that of controls which is 9.04±1.83ng/ml (P<0.001).
Conclusion: The LIF concentration in the CSF and serum may provide additional information in the differential diagnosis of meningitis. It is also concluded that LIF could be significantly involved in the pathophysiology of meningitis.
Key words: Serum, Cerebrospinal fluid, Leukemia inhibitory factor, Children, Bacterial meningitis
